Meropenem Bradex (Meropenem Anhydrous)

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It treats serious bacterial infections in hospitalized patients.

GNH USA supplies Meropenem Bradex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem Bradex is a broad‑spectrum carbapenem used to treat infections caused by resistant Gram‑negative and Gram‑positive bacteria.

- Complicated intra‑abdominal infections: achieves bacterial eradication in severe abdominal sepsis. - Complicated urinary tract infections: clears resistant uropathogens causing pyelonephritis. - Nosocomial pneumonia: effective against hospital‑acquired lung infections. - Septicemia: provides rapid bactericidal activity in bloodstream infections. - Skin and soft tissue infections: treats deep or extensive bacterial skin involvement.

Adverse reactions may occur with any antibiotic therapy. Patients should be monitored for both common and serious events.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient hepatic enzyme rise. - Injection site reactions: pain or erythema at the infusion site.

Serious or Rare Side Effects: - Seizures: especially in patients with CNS disorders or renal impairment. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Anaphylaxis: rapid onset of allergic reaction, potentially life‑threatening. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin detachment. - Renal toxicity: worsening kidney function in susceptible patients. - Thrombocytopenia: marked reduction in platelet count.

Careful assessment and monitoring are required before and during therapy with Meropenem Bradex.

- Renal function: adjust dosing in patients with impaired renal clearance. - Allergy: avoid in individuals with known carbapenem hypersensitivity. - Seizure risk: monitor patients with a history of seizures or CNS disorders. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concurrent nephrotoxic drugs: exercise caution when combined with other kidney‑affecting agents. - Store below 25°C: keep in the original container, protect from moisture and light.

Meropenem may interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Valproic acid: may lower valproate levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, heightening toxicity. - Aminoglycosides or other nephrotoxics: additive renal toxicity. - CNS stimulants (e.g., tramadol): increased likelihood of seizures. - Concurrent carbapenems: avoid simultaneous use due to overlapping toxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of meropenem. - Warfarin: possible alteration of INR, requiring coagulation monitoring. - Oral contraceptives: may reduce efficacy, advise additional contraception. - Antacids containing magnesium/aluminum: could affect reconstituted solution stability. - Immunosuppressants: monitor drug levels for potential interaction.